---
title: "Trientine - Renal cell carcinoma"
sidebar: mydoc_sidebar
permalink: db06824-mesh-d002292-1.html
toc: false 
---


Path ID: `DB06824_MESH_D002292_1`
{% include image.html url="images/db06824-mesh-d002292-1.png" file="db06824-mesh-d002292-1.png" alt="db06824-mesh-d002292-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D014266 | Trientine | Drug |
| MESH:D054856 | G-quadruplex | ChemicalSubstance |
| InterPro:IPR003545 | Telomerase | GeneFamily |
| GO:0016049 | Cell growth | BiologicalProcess |
| CL:0001063 | Tumor cell | Cell |
| MESH:D002292 | Renal cell carcinoma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Trientine | MOLECULARLY INTERACTS WITH | G-Quadruplex |
| G-Quadruplex | DECREASES ACTIVITY OF | Telomerase |
| Telomerase | NEGATIVELY REGULATES | Cell Growth |
| Cell Growth | LOCATED IN | Tumor Cell |
| Tumor Cell | CAUSES | Renal Cell Carcinoma |
|---------|-----------|---------|

Comment: Trientine is the salt form of Triethylenetetramine (DB06824)

Reference: 
  - [https://go.drugbank.com/drugs/DB06824#mechanismofaction](https://go.drugbank.com/drugs/DB06824#mechanismofaction)
  - DOI:10.1158/1535-7163.MCT-10-0523
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry](https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry)
